Publication date: September 2017
Source:Molecular Immunology, Volume 89
Author(s): Delphine El Mehdi, Federico V. Grossi, Pascal Deschatelets, Humphrey Pullon, Lisa Tan, Carolina A. Vega, Cedric G. Francois
http://ift.tt/2euZZWc
Παρασκευή 1 Σεπτεμβρίου 2017
APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου